Clinical Trial Update: Esketamine in Microelectrode Recording-guided Subthalamic Deep-Brain Stimulation for Parkinson's Disease [NA]

View source ↗

Summary

A clinical trial evaluating esketamine in microelectrode recording-guided subthalamic deep brain stimulation for Parkinson's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• SPRAVATO (ESKETAMINE HYDROCHLORIDE)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: PD - Parkinson's Disease, Deep Brain Stimulation | NA | Status: RECRUITING